Tulane Cancer Center Members: B
Faculty Membership Application and Membership Definitions
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
------------
Barnett, Batuman, Beaudoin, Beckman,Berenson, Blake, Blaya, Boh, Bunnell, Burdsal, Burow

Brian Barnett , M.D.
bbarnett@tulane.edu
(504) 988-1683
1430 Tulane Ave., Box SL-78, New Orleans, LA 70112-2699

Vecihi Batuman, M.D.
Professor of Medicine
Section of Nephrology
TCC Program Member
vbatuma@tulane.edu
(504) 988-5346, (504) 988-1909 fax
1430 Tulane Ave., Box SL-45, New Orleans, LA 70112-2699
Homepage on the Nephrology website:
http://www.som.tulane.edu/departments/nephrology/batuman.html

Biographical Narrative:
Dr. Batuman received his MD from Hacettepe University Medical School in Ankara, Turkey and completed his Internal Medicine and Nephrology training at Jersey City Medical Center, New Jersey Medical School. He was a full-time faculty member and Chief of the Renal Hypertension program in East Orange Veterans Affairs Medical Center before he joined the Tulane Program. He served as the President of the New Jersey Society of Nephrology in 1982. Dr. Batuman is certified in Internal Medicine and Nephrology by the American Board of Internal Medicine and Nephrology and is recognized as Hypertension Specialist by the American Society of Hypertension. He is a Fellow of the American College of Physicians and a member of many professional societies including the American Society of Nephrology, International Society of Nephrology and American Society of Hypertension. His current laboratory research focuses on myeloma light chain metabolism and toxicity in kidney cells, endocytic receptors that mediate endocytosis and metabolism of filtered myeloma proteins in the kidney and the role of cytokines and transcription factors in the pathogenesis of kidney disease in myeloma. Dr. Batuman's other research interests include hypertension, lead nephropathy, Balkan endemic nephropathy, environmental kidney disease and dialysis.

Selected Publications:

Christopher E. Beaudoin, Ph.D.
Assistant Professor of Community Health Sciences
TCC Associate Member
beaudoin@tulane.edu
(504) 988-4538, (504) 988-3540 fax
1430 Tulane Ave., SL-29, New Orleans, LA 70112-2699

Selected Publications:

Barbara S. Beckman, Ph.D.
Professor of Pharmacology
TCC Contributing Member
bbeckman@tulane.edu
Homepage on the Pharmacology website:
http://www.som.tulane.edu/departments/pharmacology/Faculty/Beckman.html
(504) 988-5444
1430 Tulane Ave., Box SL-83, New Orleans, LA 70112-2699

Biographical Narrative:
Dr. Beckman received her B.S. from Tulane University in 1968.  She completed her doctorate in pharmacology from Johns Hopkins University School of Medicine in 1978.  Her postdoctoral fellowship was completed under the direction of Dr. James Fisher in the area of erythropoietin signal transduction mechanisms.  In 1980 Dr. Beckman became a faculty member in the Department of Pharmacology, initially as a Research Assistant Professor, ultimately rising to the rank of tenured Professor in 1994.  Dr. Beckman has served as Co-Director and Director of the Molecular and Cellular Biology Interdisciplinary Graduate Program and has served as reviewer for the American Heart Association, NIH AIDS and related Research Study Section, Endocrinology Study Section and USAMRMC Breast Cancer Research Program.   She is currently Adjunct Professor in Otolaryngology as well as Physiology.  Dr. Beckman is a member of the American Association for Cancer Research as well as the American Society for Pharmacology and Experimental Therapeutics.  She has served as a member and Chair of the ASPET Graduate Recruitment and Education Committee. She was elected as a Fellow of the American Association for the Advancement of Science in 2005. Dr. Beckman’s primary research interests focus on understanding molecular and biochemical mechanisms of chemoresistance in breast cancer as well as hypoxia-regulated gene expression related to erythropoietin and to angiogenesis.

Selected Publications:
Gerald S. Berenson, M.D.
Clinical Professor of Medicine, Section of Cardiology
Clinical Professor of Pediatrics, Section of Pediatric Cardiology
Research Professor of Epidemiology
Director of the Tulane Center for Cardiovascular Health
Chair in Preventitive Cardiology
Principal Investigator, Bogalusa Heart Study
TCC Associate Member
berenson@tulane.edu
(504) 988-7197, (504) 988-7194 fax
1430 Tulane Ave., Box SL-29, New Orleans, LA 70112-2699
Homepage on the Cardiology website:
http://www.cardiology.tulane.edu/berenson.html
Homepage on the Epidemiology website:
http://www.epidemiology.tulane.edu/epi_pages/faculty/berenson.html

Biographical Narrative: Dr. Berenson, a native of Bogalusa, Louisiana, is a graduate of Tulane University and the Tulane School of Medicine. He has taught as a cardiologist at both Louisiana State University and Tulane University Medical Schools for over 40 years. He was Section Chief of Cardiology at LSU Medical Center for 17 years. His primary interest is in atherosclerosis, coronary artery disease, and hypertension. He is the Principal Investigator of the Bogalusa Heart Study, which has become known nationally and internationally for the study of the early natural history of heart disease. As an outgrowth of observations of poor lifestyles, unhealthy diet, smoking and inactivity contributing to obesity, he and his colleagues developed a prevention program for elementary school children, the Health Ahead/Heart Smart health education program, and a Family Health Program to control cardiovascular risk factors. Dr. Berenson's interest is in the prevention of heart disease and he encourages health education of children and families as a public health approach for preventive cardiology.

Selected Publications:
Diane A. Blake, Ph.D.
Professor of Biochemisty
TCC Contributing Member
blake@tulane.edu
Lab homepage: http://www.som.tulane.edu/labs/blake
1430 Tulane Ave., Box SL-43, New Orleans, LA 70112-2699
(504) 988-2478, (504) 988-2684 fax

Biographical Narrative:
Dr. Blake received her B.S. in Biochemistry in 1972 from Ohio State University in Columbus, Ohio. She then moved to the University of Illinois at Urbana-Champaign to study proteoglycan biosynthesis/structure with H. Edward Conrad and received her PhD in Biochemistry in 1977. After a 4-year postdoctoral fellowship studying lectin biochemistry and glycoprotein synthesis with Irwin J. Goldstein at the University of Michigan, Ann Arbor, MI, she joined Miles Laboratories as a Research Scientist in 1981. In 1983 she took a faculty position at Meharry Medical College in Nashville, TN, where she remained for 9 years. She came to Tulane in 1993 and is now Professor of Biochemistry. Dr. Blake has published over 50 papers in the areas of glycoprotein/proteoglycan biochemistry and protein-ligand interactions. She served for 5 years as a Member of the Advisory Panel for Cell Biology for the National Science Foundation and recently was a Panel Member for their Biocomplexity initiative. She has also served on Review Panels of the Environmental Protection Agency and performed ad hoc reviews for the National Institutes of Health, the Wellcome Trust (UK), and the North Carolina Biotechnology Center. She reviews regularly for Investigative Ophthalmology and Visual Sciences and Analytica Chemistry. One area of Dr. Blake's research is focused upon a study of extracellular matrix and cell-matrix interactions. Her most recent projects have included signal transduction via extracellular matrix receptors, and research on the effects of extracellular molecules on cell migration and proliferation. She has concentrated upon those extracellular matrix molecules that influence the behavior of vascular endothelial cells. A practical outcome of her experiments has been the development of new drugs (based on extracellular matrix molecules) that inhibit the process of angiogenesis. Such angiogenesis inhibitors have applications in the control of both cancer and ocular disease. A second area of active research in Blake's laboratory is the development of antibody reagents that can be used to assess human exposure to heavy metals. Some of the antibodies she has developed for this project also have applications in cancer prognosis and therapy.

Selected Publications:

Marcelo Blaya , M.D.
Assistant Professor of Medicine, Section of Hematology and Medical Oncology
TCC Contributing Member
mblaya@tulane.edu
(504) 988-5482, (504) 988-5483 fax
1430 Tulane Ave., Box SL-78, New Orleans, LA 70112-2699

 

Biographical Narrative:
Dr. Blaya received his medical degree in 1997 from the Pontificia Universidade Catolica do Rio Grande do Sul, Brazil. He went on to complete an Internal Medicine Residency at Hospital Sao Lucas da PUC, 1998-1999. Dr. Blaya then continued his training in internal medicine at Jackson Memorial Hospital, University of Miami, 2001-2004, where he received the Eric Reiss Award for Outstanding Teaching. During his fellowship (2004-2007), Dr. Blaya participated actively in the development of several clinical research projects at Sylvester Comprehensive Cancer Center in Miami, Florida. His major interest has been the development of Phase I and Phase II clinical trials for GI malignancies, such as pancreatic cancer, colorectal cancer and gastric cancer. Dr. Blaya has also been involved in several clinical projects focusing on lung and breast cancer. He joined the Tulane University faculty as an assistant professor of medicine in the Section of Hematology and Medical Oncology in 2007. At Tulane, Dr. Blaya is involved in the training of medical students, residents and fellows. He is also an active member of several medical societies, including the American Society of Clinical Oncology, the American Society of Hematology and the American Medical Association.

Selected Publications:

Erin Boh, M.D.
Professor of Dermatology
Joseph Chastain Professorship of Clinical Dermatology
Director of Dermatology Clinic at Charity Hospital MCLNO
TCC Associate Member
eboh@tulane.edu
(504) 988-5114, (504) 988-7382 fax
1430 Tulane Ave., Box TB-36, New Orleans, LA 70112-2699

Biographical Narrative:
Dr. Boh received her B.S. from Auburn University in 1973. She completed her Ph.D. studies in 1980 under Dr. Richard Steele at Tulane University, Department of Biochemistry. She then completed a year-long fellowship with the American Heart Association. Dr. Boh entered the Tulane University School of Medicine in 1981 and received her M.D. in 1985. She completed her internship at Tulane University/Charity Hospital Affiliated Programs in 1986 and completed a Dermatology Residency at Parkland Hospital in 1989. In 1989 she was Chief Resident of her Dermatology Program. Dr. Boh joined the Tulane faculty in 1990 as an Assistant Professor and is now an Associate Professor of Dermatology. Dr. Boh's research has focused on photobiology and chronic diseases such as psoriasis and skin cancers such as lymphoma. She is an international expert in photopheresis and has a strong interest in cutaneous T-Cell lymphomas and cutaneous manifestations of internal disease, both in the pediatric and adult population. In addition to participating in a number of studies in lymphoma, Dr. Boh has conducted studies on psoriasis and other chronic dermatologic diseases.

Selected Publications:

Bruce A. Bunnell , Ph.D.
Professor of Pharmacology
TCC Associate Member
bbunnell@tulane.edu
(504) 988-3329, (504) 988-7710 fax
1430 Tulane Ave., Box SL-99, New Orleans, LA 70112

Biographical Narrative:
Dr. Bruce A. Bunnell is a professor of pharmacology at the Tulane University Health Sciences Center and chairman, Division of Gene Therapy at the Tulane National Primate Research Center. He received his undergraduate education at Purdue University and his graduate training in molecular genetics at the University of Alabama at Birmingham (PhD, 1990). He did his postdoctoral training at the University of Michigan, and advanced training as a senior staff fellow at the National Human Genome Research Center at the National Institutes of Health. Dr. Bunnell held faculty positions at the Ohio State University (1998 - 2002). He joined the School of Medicine at Tulane University in 2002. Dr. Bunnell's research interests have focused on the development of gene and stem cell based therapies for lysosomal storage diseases (Sandhoff and Krabbe disease). His group is also interested in defining the biologic properties that control the stem-cell characteristics of mesenchymal stem cells.

Selected Publications:

Carol A. Burdsal, Ph.D.
Associate Professor of Cell & Molecular Biology
TCC Contributing Member
cburdsal@tulane.edu
Homepage on the CMB website: http://cell.tulane.edu/Burdsal/index.htm
(504) 862-3163, (504) 865-6785 fax
2000 Stern Hall, 6400 Freret St., New Orleans, LA 70118

Biographical Narrative:
Dr. Burdsal received her B.S. in Biology from the University of Miami at Coral Gables, FL in 1983. She then carried her doctoral research in the laboratory of Dr. David R. McClay at the Duke University on cell and adhesion and pattern formation in embryonic development. She received her Ph. D. in 1990 and then moved to the laboratory of Dr. Roger A. Pedersen at the University of California, San Francisco. There she carried out her postdoctoral research from 1990-1995 focusing on how changes in cell adhesion regulate mammalian development. In 1995, she joined the faculty of the Department of Cell and Molecular Biology at Tulane University and she reached the rank of Associate Professor in 2001. The major focus of Dr. Burdsal1s research is how growth factor signaling regulates cell-cell interactions in the developing mouse embryo. Her laboratory examines how gene expression is regulated in response to growth factor signaling during early development and organogenesis. Dr. Burdsal's lab also studies how growth factor signaling affects the cell-extracellular matrix interactions of cancer cells.

Selected Publications:

Matthew E. Burow, Ph.D.
Assistant Professor of Medicine
Section of Hematology and Medical Oncology
Adjunct Assistant Professor of Surgery
TCC Program Member
mburow@tulane.edu
(504) 988-6688, fax (504) 988-5483
1430 Tulane Ave., Box SL-78, New Orleans, LA 70112
Lab homepage:
http://www.som.tulane.edu/medhemonc/members/MBUR/index.html

Biographical Narrative:
Dr. Burow received his B.S. in Biology in 1994 at the University of Southern Mississippi. He completed his Ph.D. in 1998 at Tulane University from the Interdisciplinary Graduate Program in Molecular and Cellular Biology. Dr. Burow carried out his post-doctoral studies with Dr. John McLachlan at the Tulane/Xavier Center for Bioenvironmental Research. He was appointed in 2000 as a Research Assistant Professor in the Department of Pharmacology. In 2002 Dr. Burow accepted his current position as an Assistant Professor in the Section of Hematology and Medical Oncology, Department of Medicine with an appointment as an Adjunct Assistant Professor in the Department of Surgery. Dr. Burow's primary research interests focus on understanding the molecular mechanisms that control estrogen receptor mediated gene expression and anti-estrogen resistance in breast carcinoma cells and the way that cell survival and apoptotic signaling pathways regulate the progression of breast carcinoma to a hormone independent and drug resistant phenotype.

Selected Publications:


------------
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Return to the top of this page.
Return to the Tulane Cancer Center homepage.

Calendars Clinical Trials Faculty Links Location News
Search Site index
This page is http://www.som.tulane.edu/cancer/TCCnames/facb.html
This page was last updated on
Tulane Cancer Center, Box SL-68
1430 Tulane Avenue
New Orleans, Louisiana 70112-2699
(504) 988-6060, fax (504) 988-6077
http://www.som.tulane.edu/cancer